Long intergenic non-protein coding RNA 2763 (LINC02763)

Long intergenic non-protein coding RNA 2763 (LINC02763) is a human long non-coding RNA (lncRNA) gene that does not encode a protein and is classified as an intergenic transcript—meaning it is located between protein-coding genes in the genome[1][5][7]. It is also known as RP11-65M17.3. LINC02763 is listed in public databases such as NCBI Gene (101928823) and Ensembl (ENSG00000254968)[1][5][7]. As with many lncRNAs, its precise biological functions remain unclear and there is currently no direct evidence that it is involved in cell signaling, transcriptional regulation, or disease processes as a specific molecular target. Unlike protein-coding genes or well-characterized regulatory RNAs, LINC02763 does not have established roles as a therapeutic target, biomarker, or as a gene with clinical utility at this time[1][5][7]. The larger class of lincRNAs can play broader roles in regulating gene expression, chromatin architecture, and may have relevance in cancer biology generally, but for LINC02763 specifically, there are no published data linking it to human disease, drug interactions, or use as a molecular biomarker[1][5][7][11]. Clarifications and limitations: - LINC02763 is not a receptor, enzyme, transporter, or conventional drug target. - Currently available data do not establish it as a direct participant in disease or as a validated therapeutic target. - LINC02763 does map to human genomes and can be identified through transcriptomics databases, but clinical or experimental literature on its specific function is lacking. Summary: LINC02763 is a human long non-coding RNA gene with no demonstrated or validated functional, therapeutic, or biomarker roles as of current scientific knowledge[1][5][7][11].

Other names

RP11-65M17.3